Falagas ME - Search Results

1

Ciprofloxacin in critically ill children.

Sideri G, Kafetzis DA, Vouloumanou EK, Papadatos JH, Papadimitriou M, Falagas ME. Sideri G, et al. Among authors: falagas me. Anaesth Intensive Care. 2011 Jul;39(4):635-9. doi: 10.1177/0310057X1103900416. Anaesth Intensive Care. 2011. PMID: 21823382

2

Toxicity after prolonged (more than four weeks) administration of intravenous colistin.

Falagas ME, Rizos M, Bliziotis IA, Rellos K, Kasiakou SK, Michalopoulos A. Falagas ME, et al. BMC Infect Dis. 2005 Jan 10;5:1. doi: 10.1186/1471-2334-5-1. BMC Infect Dis. 2005. PMID: 15642116 Free PMC article.

3

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Michalopoulos AS, et al. Among authors: falagas me. Clin Microbiol Infect. 2005 Feb;11(2):115-21. doi: 10.1111/j.1469-0691.2004.01043.x. Clin Microbiol Infect. 2005. PMID: 15679485 Free article.

4

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Michalopoulos A, et al. Among authors: falagas me. Crit Care. 2005 Feb;9(1):R53-9. doi: 10.1186/cc3020. Epub 2005 Jan 6. Crit Care. 2005. PMID: 15693967 Free PMC article.

5

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Kasiakou SK, et al. Among authors: falagas me. Antimicrob Agents Chemother. 2005 Aug;49(8):3136-46. doi: 10.1128/AAC.49.8.3136-3146.2005. Antimicrob Agents Chemother. 2005. PMID: 16048915 Free PMC article. Clinical Trial.

6

Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.

Bliziotis IA, Michalopoulos A, Kasiakou SK, Samonis G, Christodoulou C, Chrysanthopoulou S, Falagas ME. Bliziotis IA, et al. Among authors: falagas me. Mayo Clin Proc. 2005 Sep;80(9):1146-56. doi: 10.4065/80.9.1146. Mayo Clin Proc. 2005. PMID: 16178494

7

Outcome of critically ill oldest-old patients (aged 90 and older) admitted to the intensive care unit.

Rellos K, Falagas ME, Vardakas KZ, Sermaides G, Michalopoulos A. Rellos K, et al. Among authors: falagas me. J Am Geriatr Soc. 2006 Jan;54(1):110-4. doi: 10.1111/j.1532-5415.2005.00544.x. J Am Geriatr Soc. 2006. PMID: 16420206

8

99mTechnetium-ciprofloxacin scintigraphy for the evaluation of spinal infections: a preliminary report.

Falagas ME, Valotassiou VJ, Papadouli D, Papadopoulos A, Malamitsi J. Falagas ME, et al. Clin Orthop Relat Res. 2006 Mar;444:34-7. doi: 10.1097/01.blo.0000201173.02883.6e. Clin Orthop Relat Res. 2006. PMID: 16523125

9

Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.

Falagas ME, Bliziotis IA, Siempos II. Falagas ME, et al. Crit Care. 2006;10(2):R48. doi: 10.1186/cc4869. Crit Care. 2006. PMID: 16563184 Free PMC article. Review.

10

Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.

Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G, Morfou P. Falagas ME, et al. J Antimicrob Chemother. 2006 Jun;57(6):1251-4. doi: 10.1093/jac/dkl130. Epub 2006 Apr 20. J Antimicrob Chemother. 2006. PMID: 16627593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

676 results

Search Page

Filters